These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23578891)

  • 1. Transplantation of novel vascular endothelial growth factor gene delivery system manipulated skeletal myoblasts promote myocardial repair.
    Zhu K; Guo C; Xia Y; Lai H; Yang W; Wang Y; Song D; Wang C
    Int J Cardiol; 2013 Oct; 168(3):2622-31. PubMed ID: 23578891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vascular endothelial growth factor gene delivery system-manipulated mesenchymal stem cells repair infarcted myocardium.
    Zhu K; Lai H; Guo C; Xu D; Wang C
    Exp Biol Med (Maywood); 2012 Jun; 237(6):678-87. PubMed ID: 22728704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair.
    Ye L; Haider HKh; Tan R; Toh W; Law PK; Tan W; Su L; Zhang W; Ge R; Zhang Y; Lim Y; Sim EK
    Circulation; 2007 Sep; 116(11 Suppl):I113-20. PubMed ID: 17846290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle based delivery of hypoxia-regulated VEGF transgene system combined with myoblast engraftment for myocardial repair.
    Ye L; Zhang W; Su LP; Haider HK; Poh KK; Galupo MJ; Songco G; Ge RW; Tan HC; Sim EK
    Biomaterials; 2011 Mar; 32(9):2424-31. PubMed ID: 21216458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor transgene expression in cell-transplanted hearts.
    Yau TM; Li G; Weisel RD; Reheman A; Jia ZQ; Mickle DA; Li RK
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1180-7. PubMed ID: 15052220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaffold-based transplantation of vascular endothelial growth factor-overexpressing stem cells leads to neovascularization in ischemic myocardium but did not show a functional regenerative effect.
    von Wattenwyl R; Blumenthal B; Heilmann C; Golsong P; Poppe A; Beyersdorf F; Siepe M
    ASAIO J; 2012; 58(3):268-74. PubMed ID: 22543757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel hyperbranched polyamidoamine nanoparticles for transfecting skeletal myoblasts with vascular endothelial growth factor gene for cardiac repair.
    Zhu K; Guo C; Lai H; Yang W; Xia Y; Zhao D; Wang C
    J Mater Sci Mater Med; 2011 Nov; 22(11):2477-85. PubMed ID: 21870080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: a promising tool to regenerate myocardial function.
    Blumenthal B; Golsong P; Poppe A; Heilmann C; Schlensak C; Beyersdorf F; Siepe M
    Artif Organs; 2010 Feb; 34(2):E46-54. PubMed ID: 20420589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with myocardial infarction.
    Li YG; Zhang PP; Jiao KL; Zou YZ
    Microvasc Res; 2009 Dec; 78(3):393-404. PubMed ID: 19595696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophages overexpressing VEGF target to infarcted myocardium and improve neovascularization and cardiac function.
    Yan D; Wang X; Li D; Liu W; Li M; Qu Z; Ruan Q
    Int J Cardiol; 2013 Apr; 164(3):334-8. PubMed ID: 21794934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transplanted myoblasts transfected with human growth hormone gene on improvement of ventricular function of rats.
    Rong SL; Lu YX; Liao YH; Wang XL; Wang YJ; Chang C; Wang YQ; Liu QY; Gao YZ; Mi SH
    Chin Med J (Engl); 2008 Feb; 121(4):347-54. PubMed ID: 18304469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential, timely and controlled expression of hVEGF165 and Ang-1 effectively improves functional angiogenesis and cardiac function in vivo.
    Zhang H; Yuan YL; Wang Z; Jiang B; Zhang CS; Wang Q; Xu XH; Dong HY; Zhang ZM
    Gene Ther; 2013 Sep; 20(9):893-900. PubMed ID: 23514706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.
    Gmeiner M; Zimpfer D; Holfeld J; Seebacher G; Abraham D; Grimm M; Aharinejad S
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1238-45. PubMed ID: 21329947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified human myoblasts with eNOS may improve regenerative ability of myogenic stem cells to infarcted heart.
    Janeczek A; Zimna A; Rozwadowska N; Fraczek M; Kucharzewska P; Ruciński M; Mietkiewski T; Kolanowski T; Malcher A; Kurpisz M
    Kardiol Pol; 2013; 71(10):1048-58. PubMed ID: 24197586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional regeneration of ischemic myocardium by transplanted cells overexpressing stromal cell-derived factor-1 (SDF-1): intramyocardial injection versus scaffold-based application.
    Blumenthal B; Poppe A; Golsong P; Blanke P; Rylski B; Beyersdorf F; Schlensak C; Siepe M
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):e135-41. PubMed ID: 21684755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts.
    Suzuki K; Murtuza B; Smolenski RT; Sammut IA; Suzuki N; Kaneda Y; Yacoub MH
    Circulation; 2001 Sep; 104(12 Suppl 1):I207-12. PubMed ID: 11568057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.
    Bonaros N; Rauf R; Wolf D; Margreiter E; Tzankov A; Schlechta B; Kocher A; Ott H; Schachner T; Hering S; Bonatti J; Laufer G
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1321-8. PubMed ID: 17140950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart.
    Niagara MI; Haider HKh; Jiang S; Ashraf M
    Circ Res; 2007 Mar; 100(4):545-55. PubMed ID: 17234963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.
    Wang Y; Haider HK; Ahmad N; Xu M; Ge R; Ashraf M
    J Mol Cell Cardiol; 2006 May; 40(5):736-45. PubMed ID: 16603183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.